Abstract Invariant chain (Ii) binds to the human leukocyte antigen (HLA) class II molecule and assists it in the process of peptide acquisition. In addition, Ii binds to the HLA class I molecule, although there has been little study of its eVects on the HLA class I molecule. In addition to its normal expression on antigen-presenting cells, Ii expression is up regulated in a variety of tumors. By Xow cytometric analysis, we found that expression of Ii resulted in an increase in the number of cell surface HLA class I molecules and in the proportion of unstable HLA class I molecules at the surface of breast tumor cell lines. These data suggest that the expression of Ii by tumor cells may quantitatively and qualitatively alter the presentation of antigens on those cells.
Introduction
Ii is a transmembrane glycoprotein that participates in the assembly of MHC class II molecule-peptide complexes in antigen-presenting cells [7] . In addition to its constitutive expression in antigen-presenting cells, Ii expression is up regulated in tumors arising from several diVerent tissues. For example, in an evaluation of colorectal carcinomas, Ii was found in 81.9% of the tumors [18] . Furthermore, in one study Ii was identiWed in a majority of cases (53 of 60) of renal cell cancer by immunohistochemistry [29] , and a separate study reported its detection in renal cell tumors by both microarray analysis and immunohistochemistry [40] . Several breast tumor cell lines have also been noted to express Ii [2] . Heightened lymphocytic inWltration was observed in vivo in breast and renal cell carcinomas that expressed Ii [15, 29] . Ii expression in tumors is not always linked to the co-expression of MHC class II molecules, as it is frequently expressed even in the absence of the MHC class II molecule [13, 15, 17, 18] .
In addition to binding to MHC class II molecules, Ii also associates with MHC class I molecules [5, 24, 25, 34, 38] . Complexes of Ii and MHC class I molecules accumulate in the cis-Golgi [38] and the endosomes [34] . Ii interacts speciWcally with the folded, 2 -microglobulin-( 2 m)-associated conformation of the MHC class I molecule, but it can be competitively displaced from the MHC molecule by the addition of peptide [5, 25, 38] . This latter observation suggests that Ii is sensitive to epitope binding by the MHC molecule, either due to Ii responsiveness to MHC conformational change upon peptide binding [5] or to direct Ii occupation of the MHC antigen binding groove and replacement by peptide. The Wnding that Ii is sensitive to MHC peptide binding suggests that it may potentially inXuence selection of peptide ligands. In this study, we questioned whether the expression of Ii in breast cancer cell lines aVected MHC class I molecule cell surface expression on those lines. Our results indicate that the level of cellular Ii inXuences the number and stability of HLA class I molecules expressed at the surface of human breast cancer cell lines. These Wndings suggest that Ii alters the peptide repertoire presented by breast tumor cells to T lymphocytes.
Materials and methods

Cell lines
The T47D, MCF-7, and MDA-MB435S human breast cancer cell lines [3, 14, 30] were gracious gifts from Dr. Shantaram Joshi, Dr. Kenneth Cowan, and Dr. Vinod Labhasetwar (respectively), University of Nebraska Medical Center, Omaha, NE, USA. The human pancreatic tumor cell lines S2-013, FG, Capan-1, Capan-2, and Hs766T [8, 10, 20, 35, 37] were provided by Dr. Michael A. Hollingsworth (University of Nebraska Medical Center). S2-013 is a cloned subline derived from the SUIT-2 human pancreatic tumor cell line, which was generated from a liver metastasis [11] . The Huh7 and DU145 prostate tumor cell lines [19, 33] and the HepG2 hepatocellular carcinoma cell line [1] were donated by Dr. Richard MacDonald (University of Nebraska Medical Center).
For S2-013, FG, Capan-1, Capan-2, Hs766T, and T47D, the basal medium used was RPMI-1640. For MCF-7, MDA-MB435S, Huh7, DU145, and HepG2, the basal medium used was DMEM. For all cell lines, the basal medium was supplemented with 10% (volume/volume) fetal bovine serum, 1 mM sodium pyruvate, 2 mM L-glutamine, penicillin (100 U/ml), streptomycin (100 g/ml), 1X non-essential amino acids, and 1X HEPES buVer. The basal media and all culture media additives were purchased from Invitrogen (Carlsbad, CA, USA), with the exception of the fetal bovine serum (which was obtained from Atlanta Biologicals, Norcross, GA, USA), and all cells were grown at 37°C in 5% CO 2 .
The human Ii p33 cDNA, a kind gift from Dr. Eric Long (NIH, Bethesda, MD, USA), was subcloned into the RSV.5neo expression vector [16] . The Ii-RSV.5neo construct was stably transfected into T47D, MCF-7, and MDA-MB435S cells with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) and selected with 600 g/ml G418 (Invitrogen, Carlsbad, CA, USA). [21] and was used as a isotype control for Xow cytometry. The hybridoma secreting monoclonal antibody BB7.2 [23] , which recognizes HLA-A2, was obtained from the American Type Culture Collection (Manassas, VA, USA). The monoclonal antibody speciWc for -tubulin was purchased from Sigma-Aldrich (St. Louis, MO, USA).
Antibodies
Immunoprecipitations and Western blots were performed by procedures similar to previously described methods [36] , with 4 ! 20% acrylamide Tris-glycine gels (Invitrogen) used for electrophoresis. Flow cytometry procedures used were similar to those described in [25] , with phycoerythrin-conjugated, Fc-speciWc F(abЈ) 2 portion of goat anti-mouse IgG (Jackson ImmunoResearch, West Grove, PA, USA). The cell analysis was performed on a FACSCalibur Xow cytometer with Cell Quest software (BD Biosciences, San Jose, CA, USA). For assessment of the cell surface HLA class I molecule turnover rate, treatments with 5 g/ml brefeldin A (Sigma-Aldrich, St. Louis, MO, USA) with subsequent Xow cytometry assays were performed [39] . Statistical analyses to compare experimental results to control results were done with SPSS software (SPSS Inc., Chicago, IL, USA).
Results
Ii was found to be endogenously expressed by the MDA-MB435S breast tumor line To begin to understand how HLA class I molecules might be aVected by Ii in tumor cells, we examined the expression of Ii by several human tumor cell lines. An Ii transfectant of T47D was also included in the Xow cytometric analysis as a positive control (Fig. 1a, b) . Among the tumor cell lines that we examined, the highest level of Ii was detected on MDA-MB435S breast tumor cells (Fig. 1a, c) . Little or no endogenous Ii was detected on the other tumor cell lines tested (Fig. 1a) . The MCF-7 breast carcinoma cell line has been reported to express Ii with a glycosylation defect [12] but in our experiments we detected no Ii in this cell line by Western blotting, although we could detect Ii expression in MDA-MB435S cells by the same Western blot (Fig. 1d) . These experiments identiWed the MDA-MB435S cell line as a breast tumor cell line that endogenously expresses intracellular and cell surface Ii.
Ii was found to increase the expression of unstable HLA class I molecules on T47D+Ii cells
To directly address the question of the eVect of Ii on cell surface HLA class I molecule expression and stability, we analyzed the T47D and T47D+Ii cell lines. By Western blotting, we conWrmed that the total level of HLA class I heavy chain was very similar in the T47D and T47D+Ii cell lines (Fig. 2a) . By a combination of immunoprecipitation and Western blotting, we found that Ii bound to HLA class I molecules in the T47D+Ii cells (Fig. 2b) . To compare the quantities of HLA class I molecules expressed at the surface of T47D and T47D+Ii breast tumor cells, HLA class I molecule expression at the surfaces of both cell lines was determined by Xow cytometry (Fig. 2c) . Our results demonstrated that transfection of Ii into T47D cells increased the expression of cell surface HLA class I molecules (Fig. 2c , compare T47D and T47D+Ii at 37°C). Since the stability of cell surface HLA class I molecules is determined by the aYnity of their bound peptides [9] , we also included in the assay T47D and T47D+Ii cells that had been incubated overnight at 25°C to determine whether assembly of the HLA class I molecules in the presence of Ii altered the presented peptide repertoire. As displayed in Fig. 2c, 25°C incubation increased the number of surface HLA class I molecules on T47D+Ii to a greater extent than on T47D. Very similar results were obtained in the same type of assay at 25 and 37°C with a second T47D+Ii transfectant and with a separate anti-MHC class I monoclonal antibody, H58A. Overall, these data suggest that the HLA class I molecules in T47D+Ii have bound to more low aYnity peptides than those in T47D.
A separate type of assay was performed to conWrm that the HLA class I molecules in T47D+Ii were acquiring a high percentage of low aYnity peptides. T47D and T47D+Ii cells were treated with brefeldin A to stop the progression of new HLA class I molecules from the endoplasmic reticulum to the cell surface [39] , and the rate of surface turnover of HLA class I molecules was monitored. The HLA class I molecules on T47D+Ii demonstrated a more rapid turnover rate than those on T47D, as shown by experiments using two time courses: 0, 1, 2, 3, and 4 h, or 0, 3, and 6 h (Fig. 2d, e) . A total of four samples were included in the assays (two per time course). The diVerence in the percentage of remaining W6/32+ HLA class I molecules on T47D+Ii versus T47D at the 3 h time point (the time point shared in both time courses) was analyzed by the Student's t test in SPSS and shown to be statistically signiWcant (P = 0.002). For the shared 3 h time point, the means of the percentages were 60.2% for T47D+Ii and 79% for T47D, and the SEM values for the percentages were very low (1.94 and 2.63, respectively), indicating reproducibility.
Thus, by two types of assays, we found the HLA class I molecules on the surface of T47D+Ii to be unusually unstable. These Wndings suggest that tumor expression of Ii may lead to changes in the spectrum of presented peptides. Furthermore, since the brefeldin A assay was performed with the cells incubated at 37°C, the greater instability of the HLA class I molecules at the surface of T47D+Ii (compared to T47D) observed in this assay conWrmed that the instability was evident at physiological temperature. Fig. 2 The expression of HLA class I molecules on the surface of T47D was elevated by Ii transfection, and HLA class I molecule expression on T47D+Ii was more unstable than on T47D. a Western blot of lysates of T47D and T47D+Ii, probed with the HC10 monoclonal antibody to identify the HLA class I heavy chain (HC). b Ii immunoprecipitation was performed on a lysate of T47D+Ii (or T47D as a control), and after transfer of the electrophoresed immunoprecipitates to a membrane, the blot was probed with the HC10 monoclonal antibody to identify the co-immunoprecipitated HLA class I heavy chain (HC). c The expression of folded HLA class I molecules was more inducible by incubation at 25°C on T47D+Ii than on T47D. T47D and T47D+Ii were incubated overnight at 25 or at 37°C and compared by Xow cytometry with W6/32. Bars display the average of the mean Xuorescence intensity values obtained with duplicate samples. d, e The HLA class I molecules at the surface of T47D+Ii have a relatively rapid turnover rate. T47D+Ii and T47D were cultured in the presence of brefeldin A, and the cells were analyzed by Xow cytometry using monoclonal antibody W6/32. Results from two assays, using diVerent time courses, are shown (0, 1, 2, 3, and 4 h in d, and 0, 3, and 6 h in e). The percentage of folded HLA class I molecules remaining at each time point was calculated by the formula [(mean Xuorescence after brefeldin A treatment after the speciWed number of hours/mean Xuorescence after brefeldin A treatment for 0 h) £ 100] and the percentages are shown on the graphs MDA-MB435S breast tumor cells endogenously expressing Ii were demonstrated to have temperature-inducible HLA class I molecules at the cell surface As mentioned above, results from Xow cytometry analysis after overnight incubation of T47D and T47D+Ii at 37 or 25°C suggested that Ii transfection resulted in increased HLA class I instability (Fig. 2c) . We reasoned that if endogenous Ii in breast tumor cells also facilitated the surface expression of unstable HLA class I molecules, we should be able to detect an increase in cell surface HLA class I on cells having endogenous Ii following incubation at 25°C. MDA-MB435S (Ii + ) and MCF-7 (Ii ¡ ) cells were incubated at 37 or 25°C and were tested the following day for HLA class I expression by Xow cytometry with monoclonal antibody W6/32. The mean Xuorescence intensity for MDA-MB435S HLA class I molecules was over 100 channels higher after 25°C than after 37°C incubation (Fig. 3 , bars labeled Assay 1). In contrast, the mean Xuorescence intensity for the HLA class I molecules expressed on MCF-7 cells was not increased at all (Fig. 3 , bars labeled Assay 1). The assay was performed a second time to conWrm the results with MDA-MB435S, and surface expression of HLA class I molecules was again observed to increase by over 100 channels following incubation of the cells at 25°C (Fig. 3 , bars labeled Assay 2). Thus, HLA class I molecules were more temperature-inducible on a cell line expressing endogenous Ii than on a cell line expressing no Ii.
Ii was demonstrated to increase the expression of unstable MHC class I molecules on other breast tumor cell lines With T47D, we had observed that increasing Ii expression raised the cell surface expression of HLA class I molecules (Fig. 2) . We also demonstrated that this Wnding could be extended to other breast tumor cell lines. MCF-7 cells were stably transfected with Ii, and Ii expression was veriWed by Western blotting (data not shown). The MCF-7+Ii cells had increased expression of HLA class I molecules at the plasma membrane, as detected by two antibodies, H58A and W6/32 (Fig. 4a) . Similar results to those shown in the Wgure were also obtained with a separate set of Xow cytometry samples. The H58A monoclonal antibody is usable for Xow cytometry and immunoprecipitation but not for Western blotting analyses of MHC class I molecules (according to the manufacturer and observations in our laboratory), which suggests that it recognizes a conformational determinant.
MDA-MB435S cells, which already express endogenous Ii (Fig. 1 ), were transfected with either Ii or with vector alone, and the resulting increased expression of Ii in MDAMB435S+Ii was conWrmed by Western blotting (data not shown). We found that MDA-MB435S cells also undergo an increase in HLA class I molecule expression when transfected with Ii, compared either to untransfected MDA-MB435S or vector-transfected MDA-MB435S cells (Fig. 4b) . The variation of mean Xuorescence intensity with the W6/32 staining in the assay results shown in Fig. 4b is very low, with SEM values <10 for all three cell lines (as shown by the error bars). Statistical analysis using the non-parametric Mann-Whitney test in the SPSS software indicated that there was a signiWcant diVerence between the HLA class I molecule surface expression on MDA-MB435S+Ii compared either to MDA-MB435S+V (P = 0.002) or MDA-MB435S (P = 0.002). Furthermore, comparable results were also obtained in a separate Xow cytometry assay. Thus, our observation that a rise in Ii expression can induce an elevation in HLA class I expression at the plasma membrane was reproducible with three diVerent human breast cancer cell lines: T47D, MCF-7, and MDA-MB435S.
Discussion
Our results from this study indicate that Ii can increase the surface expression of MHC class I molecules on human breast tumor cell lines. In addition, the low temperature inducibility and rapid surface turnover of the HLA class I The HLA class I heavy chain co-immunoprecipitated with Ii from lysates of T47D+Ii (Fig. 2) , suggesting that the intracellular binding of these two proteins is mechanistically related to the Ii-induced rise in cell surface HLA class I molecule expression. We did not detect HLA class I heavy chain interaction with Ii in MCF-7+Ii cell lysates, which may have been due to the lower intracellular level of HLA class I molecules in MCF-7 compared to T47D (data not shown).
Previous studies indicated that higher levels of surface HLA class I molecules increase the recognition of tumor cells by cytotoxic T lymphocytes (CTLs) [6, 28] . Our data indicate that Ii expression in breast tumor cells induces a quantitative increase in surface HLA class I molecule expression, and therefore increased CTL recognition may potentially result from endogenous Ii expression in tumors. Our Wndings also suggest Ii may cause HLA class I heavy chain binding of an unusually high proportion of low aYnity peptides. Presentation of a wider variety of peptide epitopes, even of low aYnity, may increase the eVectiveness of cellular immune responses to tumors expressing Ii [26, 27] . Alternatively, CTL recognition may not be increased (or may even be decreased), if there is skewed presentation of a particular low aYnity peptide or small set of peptides by Ii-expressing cells. Furthermore, CTL recognition may be decreased due to loss of the low aYnity peptides at the cell surface. Consistent with this possibility, in one study the expression of Ii in colorectal carcinomas was not found to correlate with any reduction in the rate of cancer recurrence after surgery [18] . Further studies will determine the precise nature of the changes in peptide repertoire and the eVect of Ii on T cell recognition of breast tumors in vivo. In total, these data suggest that breast tumor expression of Ii can lead to changes in the spectrum of presented peptides, in addition to changes in the number of MHC class I molecules that are present at the cell surface. 
